SI-BONE, Inc. (SIBN)Healthcare | Medical Devices | Santa Clara, United States | NasdaqGM
19.91 USD
+0.44
(2.260%)
⇧
(Oct. 15, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 11:43 a.m. EDT
The investment case for SI-BONE is currently fractured by a severe disconnect between its operational reality and its market valuation. While the company boasts impressive gross margins of nearly 80% and a fortress-like balance sheet with a current ratio of 9.1, it is hemorrhaging cash, reporting negative operating and free cash flows alongside negative earnings. This fundamental deterioration is reflected in the stock's multi-year trajectory, which has dragged down 26% over the last seven years, erasing previous gains despite a recent uptick in revenue growth. The market's reaction is starkly visible in the options chain, where traders are flooding the market with cheap put contracts at the $10 level, betting on a collapse rather than a recovery. This speculative pressure keeps the short-term outlook neutral-to-negative, as the technicals and sentiment suggest a fight against gravity. Although analysts maintain a 'strong buy' rating with a target price significantly higher than the current level, this appears to be a lagging indicator based on past potential rather than current execution. Until the company demonstrates a path to profitability and stabilizes its cash burn, the high valuation multiples remain unjustified, making this a hold for now rather than a buy. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.024000 |
| AutoARIMA | 0.024000 |
| AutoTheta | 0.024137 |
| MSTL | 0.025236 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 1.86 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.415 |
| Excess Kurtosis | -0.83 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 23.469 |
| Revenue per Share | 4.878 |
| Market Cap | 882,994,240 |
| Forward P/E | -60.18 |
| Beta | 0.66 |
| Profit Margins | -6.85% |
| Website | https://si-bone.com |
As of Oct. 10, 2026, 11:43 a.m. EDT: Speculators are positioning aggressively for downside protection with massive volume in deep out-of-the-money puts (1.9k contracts at the $10 strike), indicating a fear of a significant drop. Conversely, call activity is sparse and concentrated in far-dated January 2027 strikes, suggesting a lack of immediate bullish conviction despite the stock trading near its 52-week highs relative to the low.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.35074627 |
| Address1 | 471 El Camino Real |
| Address2 | Suite 101 |
| All Time High | 37.21 |
| All Time Low | 7.2 |
| Ask | 22.93 |
| Ask Size | 2 |
| Audit Risk | 1 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 545,550 |
| Average Daily Volume3 Month | 542,785 |
| Average Volume | 542,785 |
| Average Volume10Days | 545,550 |
| Beta | 0.664 |
| Bid | 12.96 |
| Bid Size | 2 |
| Board Risk | 9 |
| Book Value | 4.08 |
| City | Santa Clara |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 19.91 |
| Current Ratio | 9.147 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 20.05 |
| Day Low | 19.51 |
| Debt To Equity | 23.469 |
| Display Name | SI-BONE |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,785,789,000 |
| Earnings Call Timestamp Start | 1,785,789,000 |
| Earnings Timestamp | 1,785,787,200 |
| Earnings Timestamp End | 1,794,254,400 |
| Earnings Timestamp Start | 1,794,254,400 |
| Ebitda | -11,325,000 |
| Ebitda Margins | -0.05302 |
| Enterprise To Ebitda | -69.686 |
| Enterprise To Revenue | 3.695 |
| Enterprise Value | 789,191,808 |
| Eps Current Year | -0.39746 |
| Eps Forward | -0.33083 |
| Eps Trailing Twelve Months | -0.34 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 408 557 8312 |
| Fifty Day Average | 18.9438 |
| Fifty Day Average Change | 0.9661999 |
| Fifty Day Average Change Percent | 0.05100349 |
| Fifty Two Week Change Percent | 35.074627 |
| Fifty Two Week High | 21.89 |
| Fifty Two Week High Change | -1.9799995 |
| Fifty Two Week High Change Percent | -0.09045225 |
| Fifty Two Week Low | 11.48 |
| Fifty Two Week Low Change | 8.43 |
| Fifty Two Week Low Change Percent | 0.73432064 |
| Fifty Two Week Range | 11.48 - 21.89 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,539,783,000,000 |
| Float Shares | 39,982,651 |
| Forward Eps | -0.33083 |
| Forward P E | -60.181965 |
| Free Cashflow | -861,875 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 376 |
| Fullday Change | 0.44000053 |
| Fullday Change Percent | 2.2598898 |
| Fullday Price | 19.91 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.79526 |
| Gross Profits | 169,868,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03249 |
| Held Percent Institutions | 1.0956199 |
| Implied Shares Outstanding | 44,349,283 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. |
| Long Name | SI-BONE, Inc. |
| Market | us_market |
| Market Cap | 882,994,240 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_111902909 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -14,632,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 834,521,866 |
| Number Of Analyst Opinions | 9 |
| Open | 19.51 |
| Operating Cashflow | 2,478,000 |
| Operating Margins | -0.085810006 |
| Overall Risk | 6 |
| Phone | 408 207 0700 |
| Previous Close | 19.47 |
| Price Eps Current Year | -50.09309 |
| Price Hint | 2 |
| Price To Book | 4.879902 |
| Price To Sales Trailing12 Months | 4.13381 |
| Profit Margins | -0.0685 |
| Quick Ratio | 7.392 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.33333 |
| Region | US |
| Regular Market Change | 0.440001 |
| Regular Market Change Percent | 2.25989 |
| Regular Market Day High | 20.05 |
| Regular Market Day Low | 19.51 |
| Regular Market Day Range | 19.51 - 20.05 |
| Regular Market Open | 19.51 |
| Regular Market Previous Close | 19.47 |
| Regular Market Price | 19.91 |
| Regular Market Time | 1,792,094,400 |
| Regular Market Volume | 467,243 |
| Return On Assets | -0.046240002 |
| Return On Equity | -0.08297 |
| Revenue Growth | 0.152 |
| Revenue Per Share | 4.878 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 44,349,283 |
| Shares Percent Shares Out | 0.1142 |
| Shares Short | 5,116,241 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 5,626,900 |
| Short Name | SI-BONE, Inc. |
| Short Percent Of Float | 0.133 |
| Short Ratio | 9.01 |
| Source Interval | 15 |
| State | CA |
| Symbol | SIBN |
| Target High Price | 32.0 |
| Target Low Price | 20.0 |
| Target Mean Price | 25.44444 |
| Target Median Price | 25.0 |
| Total Cash | 145,940,992 |
| Total Cash Per Share | 3.256 |
| Total Debt | 42,795,000 |
| Total Revenue | 213,603,008 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.34 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 16.3147 |
| Two Hundred Day Average Change | 3.5953007 |
| Two Hundred Day Average Change Percent | 0.22037186 |
| Type Disp | Equity |
| Volume | 467,243 |
| Website | https://si-bone.com |
| Zip | 95,050 |